A Vaccine for MS?
This article represents the opinions, thoughts, and experiences of the author; none of this content has been paid for by any advertiser. The MultipleSclerosis.net team does not recommend or endorse any products or treatments discussed herein. Learn more about how we maintain editorial integrity here.
- Baylor Research Institute Immunology Researchers Obtaining Promising Results With Multiple Sclerosis Vaccine. Press Release, September 22, 2014. Accessed at http://media.baylorhealth.com/releases/baylor-research-institute-immunology-researchers-obtaining-promising-results-with-multiple-sclerosis-vaccine
- Buc M. Role of Regulatory T Cells in Pathogenesis and Biological Therapy of Multiple Sclerosis. Mediators of Inflammation, vol. 2013, Article ID 963748, 11 pages, 2013. doi:10.1155/2013/963748
- Fissolo N, Costa C, et al. Treatment with MOG-DNA vaccines induces CD4+CD25+FoxP3+ regulatory T cells and up-regulates genes with neuroprotective functions in experimental autoimmune encephalomyelitis. J Neuroinflammation. 2012 Jun 22;9:139. doi: 10.1186/1742-2094-9-139.
- Garren H, Robinson WH, et al. Phase 2 Trial of a DNA Vaccine Encoding Myelin Basic Protein for Multiple Sclerosis. Ann Neurol. 2008;63:611-620. doi: 10.1002/ana.21370 Wu GF, Laufer TM. The role of dendritic cells in multiple sclerosis. Curr Neurol Neurosci Rep. 2007 May;7(3):245-52.
- Yaday V, Bourdette DN, et al. Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study. Autoimmune Dis. 2012;2012:954739. doi: 10.1155/2012/954739. Epub 2012 Apr 5.